Dubray C
France
Research Article
Prescriptions of Proton-Pump Inhibitors Non-Compliant with Recommendations
Author(s): Bosshard T, Perez J, Pereira B, Beytout J, Dubray C, Sautou V and Lesens OBosshard T, Perez J, Pereira B, Beytout J, Dubray C, Sautou V and Lesens O
Context: In 2013, reimbursements for Proton-Pump Inhibitors (PPIs) amounted to nearly 530 million euros in France. PPI usage was subject to official recommendations in France in 2007 and 2009. Six years later, however, they are being prescribed primarily for off-label uses. This study sought to further light the prevalence of noncompliant PPI prescriptions at our institution.
Patients and methods: Transversal, descriptive, observational 1-day study including all patients receiving at least one PPI, in all conventional hospitalization and intensive care wards at a university hospital centre. The study excluded day- and week-stay hospitalization wards, the emergency department, as well as the short-term hospitalization and care ward. Besides demographic data, comorbidity was assessed based on the Charlson index. Medications that could potentia.. View More»
DOI:
10.4172/2329-6887.1000220